| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-2012-120802 |
| P698 | PubMed publication ID | 22842867 |
| P50 | author | Miia Kivipelto | Q16299902 |
| Hilkka Soininen | Q38636823 | ||
| Anna-Maija Tolppanen | Q62563371 | ||
| P2093 | author name string | Alina Solomon | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 531-540 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies | |
| P478 | volume | 32 |
| Q39404129 | 20-Year prevalence projections for dementia and impact of preventive policy about risk factors |
| Q64124512 | A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology |
| Q38316448 | A major role for cardiovascular burden in age-related cognitive decline |
| Q35322167 | Advances in the prevention of Alzheimer's disease and dementia |
| Q34873879 | Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease |
| Q58700786 | Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia |
| Q33767858 | Association between total-Tau and brain atrophy one year after first-ever stroke |
| Q47330296 | Association of Long-Term Dietary Fat Intake, Exercise, and Weight with Later Cognitive Function in the Finnish Diabetes Prevention Study |
| Q41542097 | Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine? |
| Q91610831 | Cardiovascular risk factors and memory decline in middle-aged and older adults: the English Longitudinal Study of Ageing |
| Q30733242 | Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia. |
| Q42751126 | Cholesterol-dependent energy transfer between fluorescent proteins-insights into protein proximity of APP and BACE1 in different membranes in Niemann-Pick type C disease cells. |
| Q35046906 | Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition |
| Q37467937 | Cumulative systolic blood pressure exposure in relation to cognitive function in middle-aged and elderly adults: A prospective, population-based study |
| Q37315981 | Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease. |
| Q37242461 | Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors |
| Q38850887 | Drug treatments in Alzheimer's disease. |
| Q36429211 | Early adult to midlife cardiovascular risk factors and cognitive function |
| Q92173043 | Factors associated with the onset of Alzheimer's disease: Data mining in the French nationwide discharge summary database between 2008 and 2014 |
| Q35730940 | Glucose indices are associated with cognitive and structural brain measures in young adults |
| Q26852526 | Heart failure and Alzheimer's disease |
| Q37184753 | Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future |
| Q30710587 | Imaging small vessel-associated white matter changes in aging |
| Q98952035 | Impact of benzodiazepine consumption reduction on future burden of dementia |
| Q89876303 | Incident prolonged QT interval in midlife and late-life cognitive performance |
| Q27001177 | Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms |
| Q54943031 | Is late-onset Alzheimer's disease really a disease of midlife? |
| Q33846928 | LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease |
| Q57022760 | Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease |
| Q50544227 | Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results. |
| Q33926397 | Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set |
| Q89499035 | Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS |
| Q36951659 | Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012 |
| Q33674777 | Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation |
| Q37843868 | Polyadenylation of nascent RNA during the embryogenesis of Ilyanassa obsoleta |
| Q36398793 | Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke |
| Q90634541 | Quantitative iTRAQ-based proteomic analysis of differentially expressed proteins in aging in human and monkey |
| Q48043496 | SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway |
| Q35103331 | SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice |
| Q34795067 | The association between cardiovascular risk factors and progressive hippocampus volume loss in persons with Alzheimer's disease |
| Q92824767 | The impact of cardiovascular risk factors on cognition in Hispanics and non-Hispanic whites |
| Q47660161 | The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old. |
| Q42748376 | Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach |
| Q92693125 | Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study |
| Q48762558 | Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse". |
| Q38660086 | Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. |
| Q61875198 | Vital Exhaustion and Incidence of Dementia: Results from the Copenhagen City Heart Study |
| Q92819641 | White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model |
Search more.